# US 2005/0229931 A1 · Controlling drug delivery apparatus

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2005/0229931 A1
- Document ID: US20050229931A1
- Status: Published application
- Kind: A1
- Application number: 09/930,582
- Filed: 2001-08-15
- Published: 2005-10-20
- Earliest claimed: 2000-02-11
- Assignees: Respironics (UK) Ltd.
- Inventors: Jonathan Denyer; Anthony Dyche; Richard Marsden
- Web page: https://patentgrep.com/patent/US20050229931A1

## CPC

- A61B 5/087: Measuring breath flow
- A61B 5/4839: {combined with drug delivery}
- A61M 11/005: {using ultrasonics (spraying or atomising liquids using ultrasonic vibrations in general B05B17/06)}
- A61M 15/0045: {using multiple prepacked dosages on a same carrier, e.g. blisters}
- A61M 15/008: {Electronic counters}
- G07F 17/0092: {for assembling and dispensing of pharmaceutical articles (medical dispensers for private use, A61J7/00)}
- G16H 20/13: delivered from dispensers
- A61B 5/0816: {Measuring devices for examining respiratory frequency (measuring frequency of electric signals G01R23/00)}
- A61J 1/065: {Rigid ampoules, e.g. glass ampoules}
- A61J 1/067: {Flexible ampoules, the contents of which are expelled by squeezing}
- A61J 1/14: Details; Accessories therefor (A61J7/00 takes precedence; openers B65D, B67B7/00)
- A61J 7/0481: {working on a schedule basis}
- A61J 2200/30: Compliance analysis for taking medication
- A61J 2205/50: using icons or symbolic figures, e.g. by a graphical representation symbolising the type of pathology or the organ by an image
- A61J 2205/60: using magnetic or electronic identifications, e.g. chips, RFID, electronic tags
- A61J 2205/70: Audible labels, e.g. for pre-recorded info or messages
- A61M 11/06: of the injector type
- A61M 2205/52: with memories providing a history of measured variating parameters of apparatus or patient
- A61M 2205/6018: providing set-up signals for the apparatus configuration
- Y02A 90/10: Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- G07F: COIN-FREED OR LIKE APPARATUS (coin sorting G07D3/00; coin testing G07D5/00; {handling coins or paper currencies apart from payment activated apparatus G07D; payment architectures, schemes or protocols G06Q20/00})
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- A61J: CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

A drug package comprising a plurality of drug vials containing drugs for delivery to a patient in a drug delivery device; and a data carrier including drug treatment information for use by the drug delivery apparatus.

## Claims

### Claim 1

A system for delivery of a drug to a patient comprising:
a drug delivery device arranged to deliver a dose of the drug to the patient over a plurality of breaths, the device including a breath analyser which
(i) analyses a patient's breathing during drug delivery, wherein the analysis by the breath analyser includes quantitatively measuring at least one parameter of the patient's breathing; and
(ii) generates breath information on a patient's breathing during drug delivery wherein the breath information includes the at least one quantitative measurement of the patient's breathing;
a data carrier onto which the drug delivery device is arranged to place the breath information for a number of drug deliveries;
a data analyser arranged to analyse the breath information from the data carrier, and to derive characteristics of the patient's breathing; and a trend generator of analysing the breath information and the characteristics of the patient's breathing over a number of drug deliveries.

### Claim 2

(canceled)

### Claim 3 (depends on 1)

A system according to claim 1, wherein the data analyser includes means for identifying non-compliant use of the drug delivery device.

### Claim 4

(canceled)

### Claim 5

A method of optimizing treatment from a drug delivery device which is arranged to deliver a dose of the drug to the patient over a plurality of breaths comprising:
analysing a patient's breathing during drug delivery, including quantitatively measuring at least one parameter of that breathing; generating breath information from the patient's breathing during drug delivery, including the quantitative measurements of that breathing;
transferring the breath information to a data analyser;
deriving characteristics of the patient's breathing from the breath information; and
identifying non-complaint use of the drug delivery device; and analyzing analysing the breath information and the characteristics of the patient's breathing over a number of drug deliveries.

### Claim 6

A method of identifying changes in condition of a patient over time of treatments from a drug delivery device comprising:
analysing a patient's breathing during drug delivery, including quantitatively measuring at least one parameter of that breathing; generating breath information from the patient's breathing during drug delivery, including the quantitative measurement of that breathing;
transferring the breath information to a data analyser;
deriving characteristics of the patient's breathing from the breath information; and
analysing the characteristics of the patient's treatments over a number of drug deliveries to identify trends in those characteristics.

### Claim 7 (depends on 1)

The system for delivery of a drug to a patient according to claim 1, wherein the breath information includes inhalation time and a total number of pulses, and wherein the data analyser calculates a mean inhalation time value by dividing the total inhalation time by the total number of pulses.

### Claim 8 (depends on 1)

The system for delivery of a drug to a patient according to claim 1, wherein the breath information includes inhalation time and exhalation time and wherein the data analyser calculates an inhalation to exhalation ratio value by dividing the total inhalation time by the total exhalation time.

### Claim 9 (depends on 1)

The system for delivery of a drug to a patient according to claim 1, wherein the breath information includes a total treatment time, a total inhalation time, and a total exhalation time, and wherein the data analyser calculates a total no flow time value by subtracting the total inhalation time and the total exhalation time from the total treatment time.

### Claim 10 (depends on 1)

The system for delivery of a drug to a patient according to claim 1, wherein the breath information includes a number of breaths per minute and a mean tidal volume, and wherein the data analyser calculates a minute volume value by dividing the number of breaths per minute by the mean tidal volume.

### Claim 11 (depends on 10)

The system for delivery of a drug to a patient according to claim 10, wherein the breath information further includes a mean inhalation flow and a mean inhalation time, and wherein the data analyser calculates a mean tidal volume value by multiplying the mean inhalation flow with the mean inhalation time with 0.7 and divided by 60.

### Claim 12 (depends on 1)

The system for delivery of a drug to a patient according to claim 1, wherein the breath information includes inhalation time and a total number of pulses and wherein the data analyser calculates a mean inhalation time value by dividing the total inhalation time by the total number of pulses.

### Claim 13 (depends on 6)

The method according to claim 6, wherein the step of quantitatively measuring at least one parameter includes measuring an inhalation time and measuring a total number of pulses, and wherein the step of deriving characteristics of the patient's breathing includes calculating a mean inhalation time value by dividing the total inhalation time by the total number of pulses.

### Claim 14 (depends on 6)

The method according to claim 6, wherein the step of quantitatively measuring at least one parameter includes measuring an inhalation time and an exhalation time, and wherein the step of deriving characteristics of the patient's breathing includes calculating an inhalation to exhalation ratio value by dividing the total inhalation time by the total exhalation time.

### Claim 15 (depends on 6)

The method according to claim 6, wherein the step of quantitatively measuring at least one parameter includes a total treatment time, a total inhalation time, and a total exhalation time, and wherein the step of deriving characteristics of the patient's breathing includes calculating a total no flow time value by subtracting the total inhalation time and the total exhalation time from the total treatment time.

### Claim 16 (depends on 6)

The method according to claim 6, wherein the step of quantitatively measuring at least one parameter includes measuring a number of breaths per minute and a mean tidal volume, and wherein the step of deriving characteristics of the patient's breathing includes calculating a minute volume value by dividing the number of breaths per minute by the mean tidal volume.

### Claim 17 (depends on 16)

The method according to claim 16, wherein the step of quantitatively measuring at least one parameter further includes measuring a mean inhalation flow and a mean inhalation time, and wherein the step of deriving characteristics includes calculating a mean tidal volume value by multiplying the mean inhalation flow with the mean inhalation time with 0.7 and divided by 60.

### Claim 18 (depends on 6)

The method according to claim 6, wherein the step of quantitatively measuring at least one parameter includes measuring an inhalation time and a total number of pulses, and wherein the step of deriving characteristics includes calculating a mean inhalation time value by dividing the total inhalation time by the total number of pulses.
